Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 31

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT02174848Phase 3Completed
Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration
Pantothenate Kinase-Associated Neurodegeneration
Principalinvestigator

Research Network

Collaboration Network

15 collaborators·17 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Foundation Neurological Institute C. Besta

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

9 similar investigators found

Elliott Vichinsky, MD

Children's Hospital & Research Center at Oakland Hematology/ Oncology, Pediatric Rehabilitation

Moderately Similar
1 trials

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration

Worked with same sponsors:

ApoPharma
Similarity Score30%

Penelope Hogarth, M.D.

Oregon Health and Science University

Moderately Similar
2 trials

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration
Similarity Score30%

Thomas Klopstock, Prof. Dr.

LMU Klinikum, Friedrich-Baur-Institute

Moderately Similar
1 trials

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration
Similarity Score30%

Fernando Tricta, MD

ApoPharma Inc.

Moderately Similar
3 trials

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration

Worked with same sponsors:

ApoPharma
Similarity Score30%

Thomas Klopstock, MD

Friedrich-Baur-Institute, Department of Neurology, University of Munich Ziemssenstr

Moderately Similar
1 trials

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration

Worked with same sponsors:

ApoPharma
Similarity Score30%

Susan J Hayflick, MD

Oregon Health and Science University

Moderately Similar
3 trials

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration
Similarity Score30%

Patrick Chinnery, MD

Newcastle University Institute of Human Genetics

Related
1 trials

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration

Worked with same sponsors:

ApoPharma
Collaborated on 1 trial
Similarity Score14%

Thomas Klopstock, MD

LMU Klinikum

Related
2 trials

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration

Worked with same sponsors:

ApoPharma
Collaborated on 1 trial
Similarity Score14%

Elliott Vichinsky, MD

UCSF Benioff Children's Hospital Oakland

Related
5 trials

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration

Worked with same sponsors:

ApoPharma
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02174848Phase 3PrincipalInvestigator

Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration

Pantothenate Kinase-Associated Neurodegeneration
Completed

All 1 trials loaded